| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-18 ERVK-19 ERVK-25 ERVK-24 NCSTN ERVK-8 | 7.65e-10 | 37 | 257 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-18 ERVK-19 ERVK-25 ERVK-24 NCSTN ERVK-8 | 9.92e-10 | 38 | 257 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | TAP complex binding | 4.10e-08 | 9 | 257 | 5 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 4.10e-08 | 9 | 257 | 5 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 8.12e-08 | 10 | 257 | 5 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 8.12e-08 | 10 | 257 | 5 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 8.12e-08 | 10 | 257 | 5 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.50e-07 | 12 | 257 | 5 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.85e-06 | 17 | 257 | 5 | GO:0046703 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.92e-06 | 49 | 257 | 7 | GO:0042605 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 4.50e-06 | 20 | 257 | 5 | GO:0042608 | |
| GeneOntologyMolecularFunction | peptide binding | CLSTN3 HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H TLR6 NPFFR2 KPNA7 DHCR24 NPR3 NPEPPS GRPR PTGDR2 | 1.72e-05 | 318 | 257 | 15 | GO:0042277 |
| GeneOntologyMolecularFunction | MHC class I protein binding | 5.15e-05 | 32 | 257 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 7.33e-05 | 55 | 257 | 6 | GO:0017046 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IGSF6 HLA-DPA1 ADGRB2 TAAR3P TLR6 PTGDR PTH1R FZD1 GPR146 FZD7 NPFFR2 FCRL3 PTPRN2 GLP1R C3AR1 CMKLR1 LTB4R CHRNA10 ADGRD1 VN1R2 VIPR1 NPR3 ADGRG3 GPR19 OR5M8 GRPR OR52J3 GPR161 OR52K1 TLR1 TLR5 FZD2 PTGDR2 EPHB1 | 1.40e-04 | 1353 | 257 | 34 | GO:0004888 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 LMLN ADAMTS16 ERVK-18 ERVK-19 ERVK-25 ERVK-24 KLK1 NCSTN ADAM22 USP6 ERVK-8 SENP6 PAPPA | 1.54e-04 | 430 | 257 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 1.65e-04 | 2 | 257 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | prostaglandin J receptor activity | 1.65e-04 | 2 | 257 | 2 | GO:0001785 | |
| GeneOntologyMolecularFunction | prostaglandin D receptor activity | 1.65e-04 | 2 | 257 | 2 | GO:0004956 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.96e-04 | 42 | 257 | 5 | GO:0071889 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADGRB2 TAAR3P PTGDR PTH1R FZD1 GPR146 FZD7 NPFFR2 GLP1R C3AR1 CMKLR1 LTB4R ADGRD1 VN1R2 VIPR1 NPR3 ADGRG3 GPR19 OR5M8 GRPR OR52J3 GPR161 OR52K1 FZD2 PTGDR2 | 2.00e-04 | 884 | 257 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | structural molecule activity | MYBPH ERVK-6 RELN NUP85 MRPL37 OBSCN ERVK-7 ERVK-21 MFGE8 ERVK-18 COL14A1 ERVK-19 ERVK-25 ERVK-24 OC90 SEC13 VWF CLDN23 CLDN6 CLDN2 CLDN9 ERVK-8 NUP133 ERVK-5 ZP4 | 2.25e-04 | 891 | 257 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.22e-04 | 11 | 257 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.91e-04 | 14 | 257 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | antigen binding | HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H NCR3LG1 DHCR24 PPP2CA | 8.20e-04 | 190 | 257 | 9 | GO:0003823 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 RELN ERVK-7 ERVK-21 LMLN ADAMTS16 ERVK-18 ERVK-19 ERVK-25 ERVK-24 KLK1 USP50 NPEPPS NCSTN ADAM22 USP6 ERVK-8 SENP6 PAPPA | 8.56e-04 | 654 | 257 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | MHC protein binding | 8.92e-04 | 58 | 257 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 9.73e-04 | 4 | 257 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 1.04e-03 | 16 | 257 | 3 | GO:0004953 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.25e-03 | 17 | 257 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.27e-03 | 37 | 257 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.61e-03 | 5 | 257 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.70e-03 | 133 | 257 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | amide binding | CLSTN3 INHBA TLR6 IZUMO1R PTH1R GLP1R CMKLR1 VIPR1 NPR3 TLR1 FKBP7 | 1.78e-03 | 299 | 257 | 11 | GO:0033218 |
| GeneOntologyMolecularFunction | hormone binding | 2.17e-03 | 103 | 257 | 6 | GO:0042562 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.27e-03 | 140 | 257 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.36e-03 | 21 | 257 | 3 | GO:0035613 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.60e-08 | 8 | 258 | 5 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 5.24e-07 | 25 | 258 | 6 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.15e-06 | 16 | 258 | 5 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.61e-06 | 17 | 258 | 5 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.61e-06 | 17 | 258 | 5 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 2.21e-06 | 18 | 258 | 5 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.21e-06 | 18 | 258 | 5 | GO:0042590 | |
| GeneOntologyBiologicalProcess | detection of bacterium | 3.92e-06 | 20 | 258 | 5 | GO:0016045 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 7.71e-06 | 58 | 258 | 7 | GO:0019884 | |
| GeneOntologyBiologicalProcess | detection of other organism | 8.24e-06 | 23 | 258 | 5 | GO:0098543 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 8.24e-06 | 23 | 258 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.28e-05 | 25 | 258 | 5 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.86e-05 | 48 | 258 | 6 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.50e-05 | 32 | 258 | 5 | GO:0019883 | |
| GeneOntologyBiologicalProcess | detection of external biotic stimulus | 5.25e-05 | 33 | 258 | 5 | GO:0098581 | |
| GeneOntologyBiologicalProcess | dolichol-linked oligosaccharide biosynthetic process | 1.47e-04 | 22 | 258 | 4 | GO:0006488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.53e-04 | 41 | 258 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 1.54e-04 | 9 | 258 | 3 | GO:0042270 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.72e-04 | 42 | 258 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | LRAT RELN NAAA INHBA PTH1R ACOX2 EBPL DHCR24 SCNN1B ALOX15B DPAGT1 ACOT8 SRD5A3 CUBN ALG10B PLPP6 SLC6A3 SLC34A1 LPCAT3 ALG10 | 1.76e-04 | 641 | 258 | 20 | GO:1901615 |
| GeneOntologyBiologicalProcess | dolichol metabolic process | 2.09e-04 | 24 | 258 | 4 | GO:0019348 | |
| GeneOntologyBiologicalProcess | membranous septum morphogenesis | 2.18e-04 | 10 | 258 | 3 | GO:0003149 | |
| GeneOntologyBiologicalProcess | detection of biotic stimulus | 2.66e-04 | 46 | 258 | 5 | GO:0009595 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules | 2.88e-04 | 26 | 258 | 4 | GO:0016338 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 5.89e-09 | 7 | 260 | 5 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 6.86e-08 | 10 | 260 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.12e-07 | 35 | 260 | 7 | GO:0098553 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.23e-07 | 14 | 260 | 5 | GO:0042824 | |
| GeneOntologyCellularComponent | MHC protein complex | 6.53e-07 | 26 | 260 | 6 | GO:0042611 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.25e-06 | 64 | 260 | 8 | GO:0012507 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.57e-06 | 17 | 260 | 5 | GO:0033106 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.02e-06 | 48 | 260 | 7 | GO:0098576 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 8.02e-06 | 23 | 260 | 5 | GO:0005797 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-A HLA-B HLA-C TRPM7 HLA-DPA1 SLC38A9 HLA-G HLA-H SYNDIG1 TLR6 NCDN SLC39A13 CNIH3 SPG21 SEMA4C FZD7 MFGE8 PTPRN2 NBEAL2 VPS35L SCNN1B C3AR1 CLEC16A CNGA4 AP3D1 SEC13 ADGRG3 NCSTN CUBN GPR161 MTMR4 TLR1 FZD2 EPHB1 | 3.71e-05 | 1307 | 260 | 34 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-A HLA-B HLA-C TRPM7 HLA-DPA1 SLC38A9 HLA-G HLA-H SYNDIG1 TLR6 NCDN SLC39A13 CNIH3 SPG21 SEMA4C FZD7 MFGE8 PTPRN2 NBEAL2 VPS35L SCNN1B C3AR1 CLEC16A CNGA4 AP3D1 SEC13 ADGRG3 NCSTN CUBN GPR161 MTMR4 TLR1 FZD2 EPHB1 | 4.87e-05 | 1325 | 260 | 34 | GO:0012506 |
| GeneOntologyCellularComponent | plasma membrane protein complex | HLA-A HLA-B HLA-C CATSPERD HLA-DPA1 HLA-G HLA-H TLR6 ITGA7 CNIH3 TYK2 CHRNA10 CACNA1C CACNA1D FLNA TRGV8 GJC2 NCSTN SLC6A3 ATP1B4 TRBV10-2 TRBV10-1 TRBV7-8 TLR1 | 4.96e-05 | 785 | 260 | 24 | GO:0098797 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 7.06e-05 | 110 | 260 | 8 | GO:0030134 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H TLR6 CUBN GPR161 TLR1 FZD2 | 7.40e-05 | 212 | 260 | 11 | GO:0030666 |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 7.89e-05 | 83 | 260 | 7 | GO:0030670 | |
| GeneOntologyCellularComponent | perikaryon | RELN NAIP NCDN CHRNA10 CNGA4 HSPB1 CACNA1C CACNA1D FLNA DRP2 GJC2 | 1.16e-04 | 223 | 260 | 11 | GO:0043204 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.67e-04 | 42 | 260 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 2.14e-04 | 10 | 260 | 3 | GO:0031080 | |
| GeneOntologyCellularComponent | transport vesicle membrane | HLA-A HLA-B HLA-C TRPM7 HLA-DPA1 HLA-G HLA-H SYNDIG1 CNIH3 SEMA4C PTPRN2 SEC13 | 3.24e-04 | 293 | 260 | 12 | GO:0030658 |
| GeneOntologyCellularComponent | cell projection membrane | MYO10 SLC6A19 HLA-G IZUMO1R PTH1R FCRL3 PLA2G4F CNGA4 BRWD1 CACNA1D CUBN GPR161 SLC34A1 CEACAM20 RASGRP2 | 3.50e-04 | 431 | 260 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | GATOR2 complex | 3.85e-04 | 12 | 260 | 3 | GO:0061700 | |
| GeneOntologyCellularComponent | membrane raft | MYADM HLA-A HLA-B HLA-C HLA-G HLA-H TLR6 CACNA1C SLC6A3 PPP2CA TLR1 SMPD2 EPHB1 | 6.44e-04 | 362 | 260 | 13 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | MYADM HLA-A HLA-B HLA-C HLA-G HLA-H TLR6 CACNA1C SLC6A3 PPP2CA TLR1 SMPD2 EPHB1 | 6.78e-04 | 364 | 260 | 13 | GO:0098857 |
| GeneOntologyCellularComponent | Seh1-associated complex | 9.45e-04 | 16 | 260 | 3 | GO:0035859 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 9.74e-04 | 125 | 260 | 7 | GO:0140534 | |
| GeneOntologyCellularComponent | microvillus membrane | 1.24e-03 | 38 | 260 | 4 | GO:0031528 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.52e-03 | 135 | 260 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.54e-03 | 215 | 260 | 9 | GO:0030662 | |
| GeneOntologyCellularComponent | Golgi membrane | GALNT15 CLSTN3 HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H SYNDIG1 LMTK3 GALNT7 SLC39A13 MGAT5 DHCR24 HACE1 AP3D1 NCSTN ST8SIA3 FUT1 | 1.79e-03 | 721 | 260 | 19 | GO:0000139 |
| GeneOntologyCellularComponent | coated vesicle | HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H CNIH3 SPG21 SEC13 VWF CUBN FZD2 | 1.93e-03 | 360 | 260 | 12 | GO:0030135 |
| GeneOntologyCellularComponent | lysosomal membrane | HLA-A HLA-B HLA-C HLA-DPA1 SLC38A9 HLA-G HLA-H C3AR1 CLEC16A AP3D1 SEC13 NCSTN CUBN AP5B1 | 2.04e-03 | 462 | 260 | 14 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | HLA-A HLA-B HLA-C HLA-DPA1 SLC38A9 HLA-G HLA-H C3AR1 CLEC16A AP3D1 SEC13 NCSTN CUBN AP5B1 | 2.04e-03 | 462 | 260 | 14 | GO:0098852 |
| GeneOntologyCellularComponent | transport vesicle | GALNT15 HLA-A HLA-B HLA-C TRPM7 HLA-DPA1 HLA-G HLA-H SYNDIG1 CNIH3 SPG21 SEMA4C PTPRN2 SEC13 NCSTN | 2.26e-03 | 519 | 260 | 15 | GO:0030133 |
| GeneOntologyCellularComponent | dendritic shaft | 2.29e-03 | 74 | 260 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.79e-03 | 112 | 260 | 6 | GO:0055038 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.56e-03 | 157 | 260 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 3.56e-03 | 157 | 260 | 7 | GO:0045335 | |
| GeneOntologyCellularComponent | membrane protein complex | HLA-A HLA-B HLA-C CATSPERD HLA-DPA1 SLC38A9 HLA-G HLA-H TLR6 ITGA7 CNIH3 TYK2 SCNN1B SCNN1D CHRNA10 CNGA4 AP3D1 SEC13 CACNA1C CACNA1D FLNA TRGV8 GJC2 NCSTN SLC6A3 ATP1B4 TRBV10-2 TRBV10-1 TRBV7-8 AP5B1 TLR1 | 3.67e-03 | 1498 | 260 | 31 | GO:0098796 |
| GeneOntologyCellularComponent | endosome membrane | HLA-A HLA-B HLA-C HLA-DPA1 SLC38A9 HLA-G HLA-H SYNDIG1 NCDN SPG21 FZD7 CLEC16A AP3D1 NCSTN MTMR4 EPHB1 | 3.72e-03 | 602 | 260 | 16 | GO:0010008 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.77e-03 | 201 | 260 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.19e-03 | 85 | 260 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CLSTN3 SYNDIG1 CSMD2 SEMA4C ARHGEF9 CHRNA10 HSPB1 USP50 CACNA1C DRP2 KALRN ADAM22 PDLIM5 USP6 | 4.36e-03 | 503 | 260 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | CLSTN3 SYNDIG1 CSMD2 SEMA4C ARHGEF9 HSPB1 USP50 CACNA1C DRP2 KALRN ADAM22 PDLIM5 USP6 | 4.44e-03 | 451 | 260 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | TLR6 ITGA7 CNIH3 TYK2 CHRNA10 FLNA TRGV8 TRBV10-2 TRBV10-1 TRBV7-8 TLR1 | 4.58e-03 | 350 | 260 | 11 | GO:0098802 |
| GeneOntologyCellularComponent | vacuolar membrane | HLA-A HLA-B HLA-C HLA-DPA1 SLC38A9 HLA-G HLA-H C3AR1 CLEC16A AP3D1 SEC13 NCSTN CUBN AP5B1 | 4.67e-03 | 507 | 260 | 14 | GO:0005774 |
| MousePheno | spinal cord inflammation | 2.72e-08 | 8 | 195 | 5 | MP:0030987 | |
| MousePheno | decreased immature NK cell number | 3.29e-05 | 14 | 195 | 4 | MP:0013666 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 3.53e-05 | 45 | 195 | 6 | MP:0004804 | |
| Domain | GPCR_2_secretin-like | 8.49e-08 | 60 | 246 | 9 | IPR000832 | |
| Domain | GPCR_2-like | 8.49e-08 | 60 | 246 | 9 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 9.85e-08 | 61 | 246 | 9 | PS50261 | |
| Domain | MHC_I_a_C | 4.32e-07 | 6 | 246 | 4 | IPR010579 | |
| Domain | MHC_I_C | 4.32e-07 | 6 | 246 | 4 | PF06623 | |
| Domain | MHC_I | 6.52e-06 | 21 | 246 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 6.52e-06 | 21 | 246 | 5 | IPR001039 | |
| Domain | C1-set | 6.60e-06 | 54 | 246 | 7 | PF07654 | |
| Domain | IGc1 | 8.45e-06 | 56 | 246 | 7 | SM00407 | |
| Domain | Ig/MHC_CS | 1.07e-05 | 58 | 246 | 7 | IPR003006 | |
| Domain | Ig_C1-set | 1.07e-05 | 58 | 246 | 7 | IPR003597 | |
| Domain | GPCR_2_extracellular_dom | 1.30e-05 | 40 | 246 | 6 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.30e-05 | 40 | 246 | 6 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.30e-05 | 40 | 246 | 6 | PS50227 | |
| Domain | IG_MHC | 1.35e-05 | 60 | 246 | 7 | PS00290 | |
| Domain | 7tm_2 | 4.81e-05 | 50 | 246 | 6 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.81e-05 | 50 | 246 | 6 | PS00650 | |
| Domain | MHC_I/II-like_Ag-recog | 1.34e-04 | 38 | 246 | 5 | IPR011162 | |
| Domain | Alg10 | 1.73e-04 | 2 | 246 | 2 | IPR016900 | |
| Domain | DIE2_ALG10 | 1.73e-04 | 2 | 246 | 2 | PF04922 | |
| Domain | CLAUDIN | 1.78e-04 | 22 | 246 | 4 | PS01346 | |
| Domain | Claudin_CS | 1.78e-04 | 22 | 246 | 4 | IPR017974 | |
| Domain | - | 2.54e-04 | 24 | 246 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.54e-04 | 24 | 246 | 4 | IPR011161 | |
| Domain | Ricin_B_lectin | 2.99e-04 | 25 | 246 | 4 | PF00652 | |
| Domain | HormR | 2.99e-04 | 25 | 246 | 4 | SM00008 | |
| Domain | Frizzled | 3.44e-04 | 11 | 246 | 3 | IPR000539 | |
| Domain | Frizzled | 3.44e-04 | 11 | 246 | 3 | PF01534 | |
| Domain | Frizzled | 3.44e-04 | 11 | 246 | 3 | SM01330 | |
| Domain | HRM | 4.69e-04 | 28 | 246 | 4 | PF02793 | |
| Domain | RICIN | 4.69e-04 | 28 | 246 | 4 | SM00458 | |
| Domain | Claudin | 4.69e-04 | 28 | 246 | 4 | IPR006187 | |
| Domain | RICIN_B_LECTIN | 4.69e-04 | 28 | 246 | 4 | PS50231 | |
| Domain | CAC1F_C | 5.14e-04 | 3 | 246 | 2 | IPR031688 | |
| Domain | Sestrin | 5.14e-04 | 3 | 246 | 2 | IPR006730 | |
| Domain | AhpD-like | 5.14e-04 | 3 | 246 | 2 | IPR029032 | |
| Domain | CAC1F_C | 5.14e-04 | 3 | 246 | 2 | PF16885 | |
| Domain | PA26 | 5.14e-04 | 3 | 246 | 2 | PF04636 | |
| Domain | - | 5.14e-04 | 3 | 246 | 2 | 1.20.1290.10 | |
| Domain | Ricin_B_lectin | 6.15e-04 | 30 | 246 | 4 | IPR000772 | |
| Domain | IG_LIKE | MYBPH IGSF6 HLA-A HLA-B HLA-C HLA-DPA1 HLA-G OBSCN HLA-H NCR3LG1 SEMA4C IGSF10 CILP2 FCRL3 KALRN CEACAM20 | 8.38e-04 | 491 | 246 | 16 | PS50835 |
| Domain | GPCR_2_secretin-like_CS | 9.98e-04 | 34 | 246 | 4 | IPR017983 | |
| Domain | VDCC_L_a1su | 1.02e-03 | 4 | 246 | 2 | IPR005446 | |
| Domain | Ig-like_dom | MYBPH IGSF6 HLA-A HLA-B HLA-C HLA-DPA1 HLA-G OBSCN HLA-H NCR3LG1 SEMA4C IGSF10 CILP2 FCRL3 KALRN CEACAM20 | 1.08e-03 | 503 | 246 | 16 | IPR007110 |
| Domain | Frizzled/SFRP | 1.11e-03 | 16 | 246 | 3 | IPR015526 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.22e-08 | 9 | 183 | 5 | MM14527 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.04e-07 | 6 | 183 | 4 | M47468 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 6.36e-07 | 25 | 183 | 6 | MM15713 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.33e-07 | 7 | 183 | 4 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.33e-07 | 7 | 183 | 4 | M47530 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 2.61e-06 | 18 | 183 | 5 | MM14525 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | NUP85 HLA-A HLA-B HLA-C HLA-DPA1 HLA-G HLA-H TYK2 KPNA7 CIITA SEC13 FLNA PPP2CA PPP2CB NUP133 | 2.75e-06 | 273 | 183 | 15 | M983 |
| Pathway | BIOCARTA_CTL_PATHWAY | 4.62e-06 | 20 | 183 | 5 | MM1374 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 5.58e-06 | 126 | 183 | 10 | M45009 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.45e-06 | 11 | 183 | 4 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.25e-05 | 12 | 183 | 4 | M47529 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.50e-05 | 25 | 183 | 5 | MM1465 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.80e-05 | 43 | 183 | 6 | M12617 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.22e-05 | 29 | 183 | 5 | M1062 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 5.88e-05 | 133 | 183 | 9 | M16476 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.09e-04 | 37 | 183 | 5 | M18615 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | WSB1 FBXO40 HLA-A HLA-B HLA-C HLA-G TLR6 MRC2 HACE1 SEC13 NPEPPS RNF213 FBXO44 TLR1 ASB3 | 1.35e-04 | 381 | 183 | 15 | M1066 |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.41e-04 | 117 | 183 | 8 | M19248 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.79e-04 | 41 | 183 | 5 | M13519 | |
| Pathway | WP_GPCRS_NONODORANT | ADGRB2 PTGDR PTH1R FZD1 FZD7 NPFFR2 GLP1R C3AR1 LTB4R VIPR1 GRPR FZD2 | 1.86e-04 | 266 | 183 | 12 | MM15843 |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 2.77e-04 | 129 | 183 | 8 | M39693 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.84e-04 | 98 | 183 | 7 | M965 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 3.33e-04 | 204 | 183 | 10 | M45011 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 4.54e-04 | 76 | 183 | 6 | MM14526 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 4.58e-04 | 106 | 183 | 7 | M518 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 5.22e-04 | 78 | 183 | 6 | M973 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | WSB1 FBXO40 HLA-A HLA-B HLA-C HLA-G HLA-H MRC2 HACE1 SEC13 NPEPPS RNF213 FBXO44 | 5.45e-04 | 343 | 183 | 13 | MM15712 |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 5.53e-04 | 52 | 183 | 5 | M13103 | |
| Pathway | REACTOME_TIGHT_JUNCTION_INTERACTIONS | 5.78e-04 | 30 | 183 | 4 | M17967 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 6.57e-04 | 31 | 183 | 4 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 6.57e-04 | 31 | 183 | 4 | MM15154 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 6.60e-04 | 54 | 183 | 5 | MM14871 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 7.05e-04 | 14 | 183 | 3 | M47834 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 7.05e-04 | 14 | 183 | 3 | MM15012 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | OBSCN PTGDR PTH1R FZD1 FZD7 NPFFR2 GLP1R ARHGEF9 C3AR1 CMKLR1 LTB4R VIPR1 KALRN GRPR RGS12 PPP2CA PPP2CB FZD2 PTGDR2 RASGRP2 | 8.00e-04 | 702 | 183 | 20 | M746 |
| Pathway | WP_NGLYCAN_BIOSYNTHESIS | 8.46e-04 | 57 | 183 | 5 | M48051 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 8.73e-04 | 15 | 183 | 3 | M10620 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.41e-04 | 155 | 183 | 8 | M522 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 9.90e-04 | 88 | 183 | 6 | M16004 | |
| Pathway | WP_GPCRS_ODORANT | 1.02e-03 | 157 | 183 | 8 | MM15872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 1.06e-03 | 16 | 183 | 3 | M47823 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.17e-03 | 36 | 183 | 4 | M39699 | |
| Pubmed | An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. | 1.42e-11 | 9 | 262 | 6 | 22084437 | |
| Pubmed | 1.42e-11 | 9 | 262 | 6 | 35617964 | ||
| Pubmed | 1.42e-11 | 9 | 262 | 6 | 18292501 | ||
| Pubmed | Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. | 1.42e-11 | 9 | 262 | 6 | 21300875 | |
| Pubmed | Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases. | 1.42e-11 | 9 | 262 | 6 | 17088432 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.34e-11 | 5 | 262 | 5 | 12629516 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 4.84e-10 | 7 | 262 | 5 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 4.84e-10 | 7 | 262 | 5 | 28234229 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2642506 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 9037062 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 20957233 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 4.84e-10 | 7 | 262 | 5 | 20974936 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 4.84e-10 | 7 | 262 | 5 | 2908875 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 3458188 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 19462379 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 4.84e-10 | 7 | 262 | 5 | 6300850 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 4.84e-10 | 7 | 262 | 5 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 4.84e-10 | 7 | 262 | 5 | 2906539 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 3013627 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 3894562 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 4.84e-10 | 7 | 262 | 5 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 4.84e-10 | 7 | 262 | 5 | 18383043 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8833240 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 4.84e-10 | 7 | 262 | 5 | 3025084 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 4.84e-10 | 7 | 262 | 5 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 4.84e-10 | 7 | 262 | 5 | 6786753 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6583704 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6571712 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 12006653 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 7520098 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10452993 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 26714929 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6280871 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10799615 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 4.84e-10 | 7 | 262 | 5 | 19454713 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10229092 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2879284 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 7306483 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 4.84e-10 | 7 | 262 | 5 | 1731192 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 1627536 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 4.84e-10 | 7 | 262 | 5 | 2422118 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 34181639 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 4.84e-10 | 7 | 262 | 5 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 4.84e-10 | 7 | 262 | 5 | 11894934 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 19700752 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 11894963 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 22287714 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2997361 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 9869916 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 312902 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 3335396 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6689056 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 16461341 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 4.84e-10 | 7 | 262 | 5 | 6822218 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 4.84e-10 | 7 | 262 | 5 | 19820922 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8181071 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 4.84e-10 | 7 | 262 | 5 | 6895103 | |
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 4.84e-10 | 7 | 262 | 5 | 7759137 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 4.84e-10 | 7 | 262 | 5 | 6966299 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 12140378 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 2410925 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 12421934 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 3840763 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 12421940 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 9770513 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 19195028 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 16473882 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 10479061 | ||
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 4.84e-10 | 7 | 262 | 5 | 2909618 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8168857 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 20534453 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 19342630 | ||
| Pubmed | Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs. | 4.84e-10 | 7 | 262 | 5 | 2212699 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 12817010 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 7530689 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8781130 | ||
| Pubmed | VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. | 4.84e-10 | 7 | 262 | 5 | 14630790 | |
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 1396970 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 16054612 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 8022824 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 21690324 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 7118211 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 7118212 | ||
| Pubmed | 4.84e-10 | 7 | 262 | 5 | 1370689 | ||
| Interaction | HLA-DQB1 interactions | CLSTN3 NAAA HLA-A HLA-B HLA-C HLA-DPA1 HLA-G CDC123 GXYLT1 NCSTN PI15 | 5.31e-09 | 82 | 249 | 11 | int:HLA-DQB1 |
| Interaction | LILRB1 interactions | 4.51e-06 | 10 | 249 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 4.51e-06 | 10 | 249 | 4 | int:LILRB2 | |
| Interaction | HLA-F interactions | 1.12e-05 | 86 | 249 | 8 | int:HLA-F | |
| Interaction | SCGB1C1 interactions | 1.49e-05 | 13 | 249 | 4 | int:SCGB1C1 | |
| Interaction | CD1A interactions | 3.00e-05 | 72 | 249 | 7 | int:CD1A | |
| Interaction | POMK interactions | TMEM120B CHIA NAAA HLA-A HLA-C CDC123 DHCR24 RARS2 C3AR1 VIPR1 GXYLT1 LPCAT3 ALG10 | 3.48e-05 | 271 | 249 | 13 | int:POMK |
| Interaction | HLA-DQA1 interactions | 4.70e-05 | 135 | 249 | 9 | int:HLA-DQA1 | |
| Interaction | HLA-H interactions | 4.77e-05 | 17 | 249 | 4 | int:HLA-H | |
| GeneFamily | C1-set domain containing | 3.72e-06 | 42 | 182 | 6 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.92e-06 | 44 | 182 | 6 | 588 | |
| GeneFamily | Claudins | 7.57e-05 | 23 | 182 | 4 | 488 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 1.01e-04 | 2 | 182 | 2 | 448 | |
| GeneFamily | CD molecules|Toll like receptors | 1.14e-04 | 10 | 182 | 3 | 948 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.56e-04 | 11 | 182 | 3 | 286 | |
| GeneFamily | Sodium channels epithelial | 5.97e-04 | 4 | 182 | 2 | 185 | |
| GeneFamily | Arachidonate lipoxygenases | 1.47e-03 | 6 | 182 | 2 | 407 | |
| GeneFamily | NLR family | 1.96e-03 | 25 | 182 | 3 | 666 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.46e-03 | 9 | 182 | 2 | 1230 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 3.46e-03 | 9 | 182 | 2 | 207 | |
| GeneFamily | Nucleoporins | 4.02e-03 | 32 | 182 | 3 | 1051 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 3.16e-07 | 16 | 252 | 5 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 8.22e-07 | 19 | 252 | 5 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 8.22e-07 | 19 | 252 | 5 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.09e-06 | 20 | 252 | 5 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.42e-06 | 21 | 252 | 5 | MM651 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 2.57e-06 | 90 | 252 | 8 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.89e-06 | 24 | 252 | 5 | MM3773 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 3.37e-06 | 43 | 252 | 6 | MM1204 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 3.58e-06 | 25 | 252 | 5 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.87e-06 | 44 | 252 | 6 | MM3775 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 3.87e-06 | 44 | 252 | 6 | MM805 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 5.52e-06 | 132 | 252 | 9 | MM841 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 6.63e-06 | 73 | 252 | 7 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 1.09e-05 | 31 | 252 | 5 | MM3729 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.25e-05 | 146 | 252 | 9 | MM856 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM HLA-A HLA-B PCNX3 HLA-C HLA-G HLA-H SLC39A13 SEMA4C FZD7 MFGE8 MRC2 DPAGT1 FLNA SRD5A3 CLDN9 SBNO2 PPP1R15B TRAM2 FZD2 | 1.72e-05 | 703 | 252 | 20 | MM1055 |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 1.97e-05 | 86 | 252 | 7 | MM834 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 2.02e-05 | 35 | 252 | 5 | MM674 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 2.29e-05 | 88 | 252 | 7 | MM1087 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MEGAKARYOCYTES | 2.47e-05 | 159 | 252 | 9 | MM3657 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 3.47e-05 | 166 | 252 | 9 | M7009 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 3.48e-05 | 39 | 252 | 5 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 3.48e-05 | 39 | 252 | 5 | MM3725 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP | 4.08e-05 | 131 | 252 | 8 | M40875 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 4.46e-05 | 41 | 252 | 5 | MM710 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 4.58e-05 | 172 | 252 | 9 | M2945 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN | PLBD1 CEP68 NBEAL2 SCNN1B WDR90 PLA2G4F VWF KALRN TBC1D8 FZD2 | 5.13e-05 | 217 | 252 | 10 | M34023 |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE | 5.64e-05 | 43 | 252 | 5 | M41036 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | HLA-A HLA-B HLA-C HLA-G HLA-H CIITA ADAMTS16 ALOX15B CLDN9 LPO | 6.45e-05 | 223 | 252 | 10 | MM838 |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 6.80e-05 | 181 | 252 | 9 | M8662 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 7.84e-05 | 46 | 252 | 5 | MM3712 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | GALNT15 RELN P4HA3 VPS35L SCNN1B LRCH2 KALRN CARD19 DTX1 GJC2 TMEM38B PPARGC1B EPHB1 | 9.24e-05 | 382 | 252 | 13 | M45756 |
| Coexpression | BAUS_TFF2_TARGETS_UP | 1.07e-04 | 49 | 252 | 5 | MM1287 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | PLBD1 NAIP PPM1M TLR6 PTGDR SEMA4C MRC2 CACNA1D VIPR1 VWF SRD5A3 DYNC2H1 DTX1 CNRIP1 ADAM22 RGS12 TLR5 PTGDR2 RASGRP2 | 1.09e-04 | 740 | 252 | 19 | M41202 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 1.18e-04 | 50 | 252 | 5 | MM3805 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 1.20e-04 | 114 | 252 | 7 | MM3799 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 1.30e-04 | 197 | 252 | 9 | M9537 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.30e-04 | 197 | 252 | 9 | M7545 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP | 1.40e-04 | 199 | 252 | 9 | M8294 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 1.40e-04 | 199 | 252 | 9 | M7341 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP | 1.40e-04 | 199 | 252 | 9 | M4060 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 1.42e-04 | 52 | 252 | 5 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 1.42e-04 | 52 | 252 | 5 | MM3808 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.46e-04 | 200 | 252 | 9 | M9496 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | SLC6A19 CIITA NBEAL2 ANKRD12 VIPR1 ST8SIA3 CREBBP ADAM22 PPARGC1B | 1.46e-04 | 200 | 252 | 9 | M3523 |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 1.46e-04 | 200 | 252 | 9 | M6261 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_DN | 1.46e-04 | 200 | 252 | 9 | M3082 | |
| Coexpression | MENON_FETAL_KIDNEY_10_IMMUNE_CELLS | 1.51e-04 | 83 | 252 | 6 | M39260 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 1.62e-04 | 84 | 252 | 6 | MM1049 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.96e-04 | 87 | 252 | 6 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 2.02e-04 | 56 | 252 | 5 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 2.02e-04 | 124 | 252 | 7 | MM3726 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 2.20e-04 | 57 | 252 | 5 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 2.23e-04 | 126 | 252 | 7 | MM3709 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 2.32e-04 | 168 | 252 | 8 | M7007 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 2.41e-04 | 169 | 252 | 8 | M379 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 2.51e-04 | 170 | 252 | 8 | M2942 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 2.59e-04 | 59 | 252 | 5 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 2.59e-04 | 59 | 252 | 5 | MM3704 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 2.61e-04 | 171 | 252 | 8 | M2947 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 2.66e-04 | 92 | 252 | 6 | MM3748 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_MYELOID_CELLS | 2.70e-04 | 130 | 252 | 7 | M40259 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 2.82e-04 | 93 | 252 | 6 | MM1185 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 3.05e-04 | 175 | 252 | 8 | MM3643 | |
| Coexpression | WNT_UP.V1_UP | 3.17e-04 | 176 | 252 | 8 | M2690 | |
| Coexpression | GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP | 3.17e-04 | 176 | 252 | 8 | M6716 | |
| Coexpression | DESCARTES_FETAL_LUNG_MYELOID_CELLS | 3.42e-04 | 178 | 252 | 8 | M40244 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM HLA-A HLA-B PCNX3 SLC39A13 SEMA4C FZD7 MFGE8 MRC2 DPAGT1 FLNA SRD5A3 CLDN9 SBNO2 PPP1R15B TRAM2 FZD2 | 3.47e-04 | 681 | 252 | 17 | M5314 |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 3.54e-04 | 97 | 252 | 6 | MM3789 | |
| Coexpression | GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP | 3.69e-04 | 180 | 252 | 8 | M6721 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 3.72e-04 | 137 | 252 | 7 | M41743 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 3.72e-04 | 137 | 252 | 7 | MM16612 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 3.74e-04 | 98 | 252 | 6 | MM460 | |
| Coexpression | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP | 3.95e-04 | 99 | 252 | 6 | MM1152 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 4.06e-04 | 139 | 252 | 7 | M9006 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 4.17e-04 | 100 | 252 | 6 | MM458 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 4.27e-04 | 184 | 252 | 8 | M6696 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 4.42e-04 | 185 | 252 | 8 | M40148 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 4.82e-04 | 143 | 252 | 7 | MM1056 | |
| Coexpression | ZHANG_UTERUS_C12_MONOCYTE | 4.92e-04 | 188 | 252 | 8 | MM16618 | |
| Coexpression | YU_MYC_TARGETS_DN | 5.02e-04 | 68 | 252 | 5 | MM632 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | ILK SPG21 AGO3 CDC123 PXN MIGA1 SEC13 RNF213 MTMR4 FBXO44 TLR1 | 5.12e-04 | 342 | 252 | 11 | M41062 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 5.24e-04 | 238 | 252 | 9 | MM3728 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | NAAA TRPM7 INHBA ADGRB2 P4HA3 PTH1R SLC39A13 FZD1 IGSF10 SIAE AGO3 MRC2 ARHGEF9 ADAMTS16 COL14A1 ANKRD12 CACNA1C VWF GPR19 LRCH2 SLC27A6 DTX1 CAMLG CNRIP1 RAD9B PI15 ADAM22 TGFB1I1 SENP6 FKBP7 PAPPA CFAP61 | 3.15e-06 | 1166 | 240 | 32 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGSF6 HLA-B HLA-DPA1 NAIP TLR6 SAT1 CIITA C3AR1 CMKLR1 WDFY4 TLR1 | 1.74e-08 | 198 | 250 | 11 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGSF6 HLA-DPA1 NAIP TLR6 SAT1 CIITA C3AR1 CMKLR1 RNF213 WDFY4 TLR1 | 1.83e-08 | 199 | 250 | 11 | 5ceeed92f831d068ff4bb3994f420002338330e7 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RASL12 ITGA7 PTH1R MFGE8 GLP1R COL14A1 HSPB1 CACNA1C FLNA TGFB1I1 | 1.06e-07 | 186 | 250 | 10 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | RASL12 ITGA7 PTH1R MFGE8 GLP1R COL14A1 CACNA1C NPR3 KALRN PI15 | 1.36e-07 | 191 | 250 | 10 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | Kidney-Mesangial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | ITGA7 MFGE8 HSPB1 CACNA1C FLNA TRIM51 CLDN9 TGFB1I1 ZIC5 RASGRP2 | 1.73e-07 | 196 | 250 | 10 | 2b2cbe7f96213b7ff50442593f31820d17a2ae94 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGSF6 HLA-DPA1 NAIP TLR6 SAT1 CIITA C3AR1 CMKLR1 RNF213 TLR1 | 1.82e-07 | 197 | 250 | 10 | 10190b877bf46ba2163d203df9dd3b498c66e52f |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-07 | 199 | 250 | 10 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | ILK INHBA RASL12 ITGA7 MFGE8 HSPB1 FLNA PDLIM5 TGFB1I1 RASGRP2 | 2.09e-07 | 200 | 250 | 10 | 8b80a65b69b36ed405214564b939452c90aa40d6 |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | ILK INHBA RASL12 ITGA7 MFGE8 HSPB1 FLNA PDLIM5 TGFB1I1 RASGRP2 | 2.09e-07 | 200 | 250 | 10 | 2bc7f462a551292de2501028164573935232f899 |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 161 | 250 | 9 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-07 | 168 | 250 | 9 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-07 | 168 | 250 | 9 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.84e-07 | 172 | 250 | 9 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.44e-07 | 174 | 250 | 9 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 7.43e-07 | 177 | 250 | 9 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 7.79e-07 | 178 | 250 | 9 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 185 | 250 | 9 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 185 | 250 | 9 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 185 | 250 | 9 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 186 | 250 | 9 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 186 | 250 | 9 | c0a58e43a813441d3a1708236737b15db8bea10e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 186 | 250 | 9 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 187 | 250 | 9 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 1.23e-06 | 188 | 250 | 9 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 190 | 250 | 9 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 190 | 250 | 9 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 190 | 250 | 9 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.40e-06 | 191 | 250 | 9 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 1.59e-06 | 194 | 250 | 9 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 250 | 9 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 250 | 9 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 250 | 9 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.59e-06 | 194 | 250 | 9 | 640ff8da7084a9486fc2752493b8d8059ecf4ab7 | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.66e-06 | 195 | 250 | 9 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 1.66e-06 | 195 | 250 | 9 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.73e-06 | 196 | 250 | 9 | 21ad9a63242e33038f9f531dd4074a5a9304ed62 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.73e-06 | 196 | 250 | 9 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.73e-06 | 196 | 250 | 9 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-06 | 197 | 250 | 9 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-06 | 198 | 250 | 9 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-06 | 198 | 250 | 9 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RASL12 ITGA7 PTH1R MFGE8 COL14A1 CACNA1C KALRN PDLIM5 TGFB1I1 | 1.96e-06 | 199 | 250 | 9 | b1753474152b82a0b811b9878c890a359e14919a |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-06 | 200 | 250 | 9 | fc802dd73f048881d9ddafd1b79ab3ca654510e2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-06 | 200 | 250 | 9 | cffddb39960cd611428397c1ec4023192e8af5a7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-06 | 200 | 250 | 9 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD16+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 2.05e-06 | 200 | 250 | 9 | 5c0eb14bdf1bfeaf93f6c3d521529bd5a4de50ce | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-06 | 200 | 250 | 9 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 2.15e-06 | 105 | 250 | 7 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.32e-06 | 112 | 250 | 7 | ef8fdb35a4d295f7e4a0a4029e5965c1f17e413a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.50e-06 | 160 | 250 | 8 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.67e-06 | 161 | 250 | 8 | 39030380e04f57f8e7de231577ec3177e1b6490d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-06 | 163 | 250 | 8 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-06 | 166 | 250 | 8 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 166 | 250 | 8 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 4.81e-06 | 167 | 250 | 8 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-06 | 169 | 250 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-06 | 171 | 250 | 8 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.85e-06 | 122 | 250 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 173 | 250 | 8 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 173 | 250 | 8 | 3001dd39244ef0a5a475d569a78f4ae427a55db6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 173 | 250 | 8 | c88883fb2a33e21d4201aa393674aa3f2ad780c9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 173 | 250 | 8 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.51e-06 | 174 | 250 | 8 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 175 | 250 | 8 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 6.78e-06 | 175 | 250 | 8 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 175 | 250 | 8 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 6.78e-06 | 175 | 250 | 8 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.78e-06 | 175 | 250 | 8 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 250 | 8 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 250 | 8 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-06 | 176 | 250 | 8 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.07e-06 | 176 | 250 | 8 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.37e-06 | 177 | 250 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.62e-06 | 127 | 250 | 7 | ca77f85502dd66f3cb4b15cf80f755104ca1e6ff | |
| ToppCell | Hippocampus-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.62e-06 | 127 | 250 | 7 | b27d5141e661a4c6924aa6d7c5b046f9ae49955d | |
| ToppCell | Hippocampus-Macroglia-CSF_related-CHOROID_PLEXUS|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.62e-06 | 127 | 250 | 7 | 25d0b28c9df2d10fbcdb0aca47b75bf5c7c9c430 | |
| ToppCell | Hippocampus-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.62e-06 | 127 | 250 | 7 | 352d44233a93c926aeb7c5fad49965fd82b873ca | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 7.68e-06 | 178 | 250 | 8 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.01e-06 | 179 | 250 | 8 | ae9d90a4eac2cfa545a764df84914c5801544278 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-06 | 180 | 250 | 8 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.34e-06 | 180 | 250 | 8 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-06 | 181 | 250 | 8 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | c1b1e62440805800a3a600b1ddd79be1c9762598 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.68e-06 | 181 | 250 | 8 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.68e-06 | 181 | 250 | 8 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.04e-06 | 182 | 250 | 8 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.04e-06 | 182 | 250 | 8 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-06 | 183 | 250 | 8 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 183 | 250 | 8 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 183 | 250 | 8 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.41e-06 | 183 | 250 | 8 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 9.41e-06 | 183 | 250 | 8 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-06 | 184 | 250 | 8 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-06 | 184 | 250 | 8 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Immature_B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.79e-06 | 184 | 250 | 8 | e6669a1b7ea7e4f8e094add5117689470019d85d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 185 | 250 | 8 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-05 | 185 | 250 | 8 | 42690b95e2e7d56c822211bb1150acb787cfe2e8 | |
| Computational | Genes in the cancer module 293. | 1.22e-05 | 12 | 139 | 4 | MODULE_293 | |
| Computational | Genes in the cancer module 27. | IGSF6 HLA-A HLA-B HLA-C HLA-G ADGRB2 PTH1R CIITA PTPRN2 C3AR1 VIPR1 NPR3 GRPR TLR1 FZD2 EPHB1 | 1.34e-05 | 355 | 139 | 16 | MODULE_27 |
| Computational | Genes in the cancer module 143. | 2.42e-05 | 14 | 139 | 4 | MODULE_143 | |
| Computational | Neighborhood of BMPR2 | 1.11e-04 | 85 | 139 | 7 | GCM_BMPR2 | |
| Computational | Neighborhood of INPP5D | 2.18e-04 | 43 | 139 | 5 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 3.34e-04 | 47 | 139 | 5 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 3.34e-04 | 47 | 139 | 5 | GNF2_PTPN6 | |
| Computational | Genes in the cancer module 146. | 3.45e-04 | 102 | 139 | 7 | MODULE_146 | |
| Computational | Neighborhood of CD48 | 7.27e-04 | 32 | 139 | 4 | GNF2_CD48 | |
| Drug | P-31 | 2.04e-06 | 20 | 249 | 5 | CID000017959 | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A | SAMD9 NAAA TMCO6 SEMA4C SSH3 ARHGEF9 CLEC16A NPR3 SBNO2 SENP6 FUT1 TRAM2 | 2.24e-06 | 200 | 249 | 12 | 5842_DN |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | WSB1 SAT1 PTPRN2 MRC2 RECQL5 ARHGEF9 KLK1 GPR19 DYNC2H1 VPS13D EPHB1 | 9.22e-06 | 192 | 249 | 11 | 2572_UP |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; HL60; HG-U133A | WSB1 CEP68 DNAJC10 SAT1 LTB4R KLK1 DYNC2H1 NSD2 LPCAT3 RASGRP2 EPHB1 | 1.18e-05 | 197 | 249 | 11 | 2009_UP |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A | NAAA NCDN ACOX2 CEP68 SAT1 SSH3 NBEAL2 VPS35L BRWD1 NPR3 VPS13D | 1.23e-05 | 198 | 249 | 11 | 2094_DN |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.57e-07 | 7 | 244 | 4 | DOID:0081267 (implicated_via_orthology) | |
| Disease | allergic asthma (is_implicated_in) | 5.52e-06 | 5 | 244 | 3 | DOID:9415 (is_implicated_in) | |
| Disease | asthma (is_implicated_in) | 6.82e-06 | 157 | 244 | 9 | DOID:2841 (is_implicated_in) | |
| Disease | – | 6.81e-05 | 2 | 244 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 6.81e-05 | 2 | 244 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 6.81e-05 | 2 | 244 | 2 | cv:CN077964 | |
| Disease | tuberculosis (is_implicated_in) | 7.99e-05 | 28 | 244 | 4 | DOID:399 (is_implicated_in) | |
| Disease | beta-2 microglobulin measurement | 8.77e-05 | 11 | 244 | 3 | EFO_0005197 | |
| Disease | Paranoia | 8.77e-05 | 11 | 244 | 3 | C1456784 | |
| Disease | childhood onset asthma | HLA-A HLA-B HLA-DPA1 SYNDIG1 TMCO4 CIITA CLEC16A SBNO2 AP5B1 TLR1 EPHB1 | 1.16e-04 | 334 | 244 | 11 | MONDO_0005405 |
| Disease | Colonic Polyps | 2.03e-04 | 3 | 244 | 2 | C0009376 | |
| Disease | Long Qt Syndrome 2 | 2.03e-04 | 3 | 244 | 2 | C3150943 | |
| Disease | Addison Disease | 2.03e-04 | 3 | 244 | 2 | C0001403 | |
| Disease | severe aplastic anemia | 2.36e-04 | 15 | 244 | 3 | EFO_0006927 | |
| Disease | JT interval | 2.38e-04 | 248 | 244 | 9 | EFO_0007885 | |
| Disease | pulse pressure measurement | HLA-B TRPM7 INHBA NCR3LG1 CEP68 CILP2 CDC123 MRC2 CLEC16A AP3D1 USP50 CACNA1D NPR3 GPR19 DYNC2H1 CNRIP1 RNF213 DEFB136 SIPA1 PI15 CLDN23 PDLIM5 PBRM1 ASB3 FZD2 | 2.43e-04 | 1392 | 244 | 25 | EFO_0005763 |
| Disease | Muscle hypotonia | 3.49e-04 | 17 | 244 | 3 | C0026827 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.49e-04 | 17 | 244 | 3 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 4.04e-04 | 4 | 244 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | lactotransferrin measurement | 4.04e-04 | 4 | 244 | 2 | EFO_0020526 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 4.04e-04 | 4 | 244 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Disproportionate short stature | 4.52e-04 | 77 | 244 | 5 | C0878659 | |
| Disease | sucrose liking measurement | 5.74e-04 | 20 | 244 | 3 | EFO_0010157 | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 6.70e-04 | 5 | 244 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | Addison's disease (is_implicated_in) | 6.70e-04 | 5 | 244 | 2 | DOID:13774 (is_implicated_in) | |
| Disease | Macrothrombocytopenia | 6.70e-04 | 5 | 244 | 2 | C2751260 | |
| Disease | chronic myeloid leukemia (implicated_via_orthology) | 6.70e-04 | 5 | 244 | 2 | DOID:8552 (implicated_via_orthology) | |
| Disease | Moyamoya disease (is_implicated_in) | 6.70e-04 | 5 | 244 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | prostate cancer, disease progression measurement | 9.94e-04 | 24 | 244 | 3 | EFO_0008336, MONDO_0008315 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 9.99e-04 | 6 | 244 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | systemic lupus erythematosus | HLA-A PCNX3 HLA-DPA1 ACOX2 TYK2 MGAT5 FCRL3 CIITA CLEC16A GPR19 SIPA1 WDFY4 CLDN23 SBNO2 SLC34A1 AP5B1 | 1.08e-03 | 799 | 244 | 16 | MONDO_0007915 |
| Disease | Hermansky-Pudlak syndrome (is_implicated_in) | 1.39e-03 | 7 | 244 | 2 | DOID:3753 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | KDM3A SRARP OBSCN MFGE8 FCRL3 SCNN1B ACCS DPAGT1 FLNA VWF KALRN DYNC2H1 ZSWIM5 NSD2 CUBN SLC6A3 PPARGC1B PBRM1 NUP133 | 1.62e-03 | 1074 | 244 | 19 | C0006142 |
| Disease | non-melanoma skin carcinoma | 1.72e-03 | 265 | 244 | 8 | EFO_0009260 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.74e-03 | 29 | 244 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.74e-03 | 29 | 244 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.74e-03 | 29 | 244 | 3 | C3658302 | |
| Disease | respiratory failure, COVID-19 | 1.74e-03 | 29 | 244 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Toxic Epidermal Necrolysis | 1.74e-03 | 29 | 244 | 3 | C0014518 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 1.75e-03 | 62 | 244 | 4 | EFO_0004616, EFO_1000786 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 1.85e-03 | 8 | 244 | 2 | DOID:1312 (is_marker_for) | |
| Disease | aspergillosis (is_implicated_in) | 1.85e-03 | 8 | 244 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 1.85e-03 | 8 | 244 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | Hepatitis B, Chronic | 1.85e-03 | 8 | 244 | 2 | C0524909 | |
| Disease | Stevens-Johnson Syndrome | 1.92e-03 | 30 | 244 | 3 | C0038325 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.97e-03 | 64 | 244 | 4 | EFO_0000685, MONDO_0100096 | |
| Disease | eosinophil measurement | 2.07e-03 | 108 | 244 | 5 | EFO_0803540 | |
| Disease | treatment-resistant hypertension | 2.16e-03 | 109 | 244 | 5 | EFO_1002006 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.36e-03 | 9 | 244 | 2 | DOID:988 (is_implicated_in) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 2.36e-03 | 9 | 244 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.45e-03 | 68 | 244 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | asthma, age at onset | 2.73e-03 | 70 | 244 | 4 | EFO_0004847, MONDO_0004979 | |
| Disease | Malignant Glioma | 2.73e-03 | 70 | 244 | 4 | C0555198 | |
| Disease | mixed gliomas | 2.73e-03 | 70 | 244 | 4 | C0259783 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.77e-03 | 34 | 244 | 3 | EFO_0009926 | |
| Disease | allergic disease, age at onset | 2.87e-03 | 71 | 244 | 4 | EFO_0004847, MONDO_0005271 | |
| Disease | Hermanski-Pudlak Syndrome | 2.93e-03 | 10 | 244 | 2 | C0079504 | |
| Disease | Hermansky-Pudlak syndrome | 2.93e-03 | 10 | 244 | 2 | cv:C0079504 | |
| Disease | thyroid peroxidase antibody measurement | 3.02e-03 | 72 | 244 | 4 | EFO_0005666 | |
| Disease | eosinophil count | HLA-A HLA-B HLA-C HLA-DPA1 HLA-G PTGDR SESN1 KPNA7 CILP2 MGAT5 CIITA CLEC16A HSPB1 DNMT3L USP50 FLNA SCAND2P SESN3 SBNO2 PBRM1 LPCAT3 LPO NUP133 | 3.07e-03 | 1488 | 244 | 23 | EFO_0004842 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.26e-03 | 36 | 244 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Hypoglycemia | 3.57e-03 | 11 | 244 | 2 | C0020615 | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 3.57e-03 | 11 | 244 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | acne | 3.89e-03 | 125 | 244 | 5 | EFO_0003894 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 4.03e-03 | 126 | 244 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | diastolic blood pressure, systolic blood pressure | HLA-DPA1 MFGE8 CDC123 MRC2 CLEC16A CACNA1C CACNA1D DYNC2H1 RGS12 PDLIM5 PLPP6 ZIC5 ASB3 | 4.06e-03 | 670 | 244 | 13 | EFO_0006335, EFO_0006336 |
| Disease | dermatomyositis | 4.26e-03 | 12 | 244 | 2 | EFO_0000398 | |
| Disease | mood disorder | 5.00e-03 | 13 | 244 | 2 | EFO_0004247 | |
| Disease | male infertility (implicated_via_orthology) | 5.00e-03 | 13 | 244 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | primary biliary cirrhosis | 5.06e-03 | 133 | 244 | 5 | EFO_1001486 | |
| Disease | Prostatic Neoplasms | SAMD9 TLR6 DNAJC10 NPR3 SESN3 CREBBP GRPR CLDN9 FBXO44 TLR5 SENP6 ALOXE3 | 5.51e-03 | 616 | 244 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | SAMD9 TLR6 DNAJC10 NPR3 SESN3 CREBBP GRPR CLDN9 FBXO44 TLR5 SENP6 ALOXE3 | 5.51e-03 | 616 | 244 | 12 | C0376358 |
| Disease | Chagas cardiomyopathy | 5.76e-03 | 44 | 244 | 3 | EFO_0005529 | |
| Disease | sex interaction measurement, longitudinal BMI measurement, age at assessment | 5.80e-03 | 14 | 244 | 2 | EFO_0005937, EFO_0008007, EFO_0008343 | |
| Disease | chronic kidney disease (is_implicated_in) | 5.80e-03 | 14 | 244 | 2 | DOID:784 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.82e-03 | 195 | 244 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Glioma | 5.94e-03 | 87 | 244 | 4 | C0017638 | |
| Disease | descending aortic diameter | 6.18e-03 | 88 | 244 | 4 | EFO_0021788 | |
| Disease | liver neoplasm | 6.66e-03 | 15 | 244 | 2 | EFO_1001513 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 6.66e-03 | 15 | 244 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Proteinuria | 6.66e-03 | 15 | 244 | 2 | HP_0000093 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 6.66e-03 | 15 | 244 | 2 | EFO_0801746 | |
| Disease | neuropathic pain | 6.93e-03 | 47 | 244 | 3 | EFO_0005762 | |
| Disease | stroke | 7.04e-03 | 144 | 244 | 5 | EFO_0000712 | |
| Disease | age of onset of childhood onset asthma | 7.22e-03 | 92 | 244 | 4 | OBA_2001015 | |
| Disease | frontal fibrosing alopecia | 7.34e-03 | 48 | 244 | 3 | EFO_0009855 | |
| Disease | alcohol consumption measurement | GALNT15 RELN HLA-B P4HA3 SYNDIG1 GALNT7 SLC39A13 CNIH3 FZD7 HACE1 WDR90 CLEC16A CACNA1C CACNA1D ST8SIA3 RGS12 ALG10B ASB3 SENP6 | 7.69e-03 | 1242 | 244 | 19 | EFO_0007878 |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 7.78e-03 | 49 | 244 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPLFVAAICAHWFQY | 641 | Q13075 | |
| AAICAHWFQYPFDPS | 646 | Q13075 | |
| FPFDAQHCGLTFGSW | 161 | Q9GZZ6 | |
| SDYAFLGTALLPHQW | 231 | O14734 | |
| VAYWGLPSFARCISH | 576 | O60241 | |
| FIFCHELLDYWGSEV | 281 | P49069 | |
| ADFLCPELYTTAWAH | 491 | Q99424 | |
| PQEHLCWIIFNGTIY | 236 | Q96N23 | |
| SYFTEPWCLALFHDR | 1141 | Q8NHU2 | |
| IIDWAPRGQFYHNCS | 151 | O42043 | |
| TIIDWAPRGQFYHNC | 261 | O71037 | |
| TIIDWAPRGQFYHNC | 261 | Q902F8 | |
| NQAWHLVTHECPNYF | 316 | O95154 | |
| SLTVHGCRIAFLYWP | 411 | Q9BQT9 | |
| PFFWNRENYVSCHDP | 641 | Q86XM0 | |
| FPIQYDNNAHCVWII | 421 | Q7Z408 | |
| RLSFQAEYWACVLPD | 266 | Q76N32 | |
| TCDRPPSWYLFQFHR | 251 | Q9UJW3 | |
| EPSLLQYADWRGHLF | 126 | Q96QU6 | |
| FQVLASASHYWPLEN | 36 | Q6QNK2 | |
| AWACGRLPQYDFVFS | 436 | P33076 | |
| PCAYTWFLLDSILSH | 196 | Q6UY09 | |
| TPVLFFYGSNWDSHC | 196 | Q15760 | |
| WIGSDCNTYFPHNDD | 706 | Q9P0K1 | |
| LHYDIIWPSGFVCDN | 1296 | Q92793 | |
| GLYPVANNRNAFWHC | 436 | Q9BZP6 | |
| FYDCRVEHWGLDQPL | 191 | P20036 | |
| GILYSWQFPHFNALS | 316 | Q12887 | |
| AACWARGAVFHYFLL | 336 | Q86Y34 | |
| QRYCEGHFSLSQWDP | 46 | Q5I7T1 | |
| SRPSHYHVLWDDNCF | 761 | Q9H9G7 | |
| FAGWTPLHEACNVGY | 216 | Q6UB98 | |
| FLVCWTPYHIFGVLS | 386 | Q16581 | |
| HWSFPYKQEIFELCI | 876 | Q96F81 | |
| HSDFPWAPQFFLHCL | 861 | A7MBM2 | |
| EPDTWQHYVISLNGF | 171 | Q9UN42 | |
| NGVFSWSPCSRQYLH | 466 | Q8TE57 | |
| GPCFLEHQDGFWIYS | 181 | O43307 | |
| VLYAAAWICGEFSEH | 481 | O14617 | |
| CEYAAAPVARLASHW | 136 | P17342 | |
| NDWIIAPSGYHANYC | 336 | P08476 | |
| PRNCERYLNWAHAFL | 81 | Q9NYN1 | |
| MALECWLSLGHPFFY | 126 | Q13258 | |
| IYPFAHWLAFGNSSV | 416 | Q9Y5X5 | |
| LGALYWACVHNDPTQ | 96 | Q7Z3H0 | |
| HEATLRCWALGFYPA | 221 | P01893 | |
| SYGPEFAHCREIQWN | 151 | Q92542 | |
| TPLAENGVRQCYHYW | 846 | Q92932 | |
| WLSYHVLQASEPGLF | 601 | Q9UN71 | |
| WIHEYGQEFRRPCSS | 526 | Q7Z4N8 | |
| CVLFSPVFFQHYQWS | 51 | Q6WBX8 | |
| HPVFDYEATLRCWAL | 216 | P17693 | |
| LWAHTPYTFDIQAIN | 396 | P54762 | |
| AAAWHSADNPCLIYY | 356 | Q8WUM0 | |
| CWFYRPNETFHLATR | 996 | Q86U86 | |
| LYPCLQFEAAWALTN | 126 | A9QM74 | |
| FHSEIFQYTVVWGPC | 1086 | Q14667 | |
| FAYISCAAAILPFWE | 291 | Q7Z418 | |
| YDPFHNCWSEAAPLL | 441 | Q8WZ60 | |
| CEQHSQPWQAALYHF | 31 | P06870 | |
| QPWQAALYHFSTFQC | 36 | P06870 | |
| CKYFLQQWELTSPGH | 491 | Q9UBB6 | |
| CHLVRYWISAFPAEF | 76 | Q7LDG7 | |
| GLHLFSWNPSYARLD | 256 | Q08431 | |
| FIYLSEVENWCPHLP | 186 | Q09328 | |
| SWEAHLDVSPLYNFS | 61 | A6ND01 | |
| PLNGAWFRVETNYDH | 276 | Q02083 | |
| VCYDAFAPLSHVRFW | 66 | Q5T442 | |
| WASSVPQGHVYRFCT | 91 | P43220 | |
| PQGHVYRFCTAEGLW | 96 | P43220 | |
| CWYFHQTAIPCLLAL | 616 | Q96T76 | |
| ADYWILAEAPTHCLN | 326 | Q9BYJ1 | |
| EHLIFFCTRAWPSYQ | 316 | Q68D85 | |
| QCTAWLNAYFHQPEA | 61 | P16455 | |
| EIADYCPFSQEFSWH | 476 | Q96KR4 | |
| CPFSQEFSWHLSGEY | 481 | Q96KR4 | |
| WELFEFGAQPYRHLS | 341 | Q96Q04 | |
| AWANHVFLGCRYPQK | 81 | Q9NXV6 | |
| GCRTFHWFLANVYPE | 481 | Q8N3T1 | |
| HNWYPSRVFVGDTFC | 241 | Q9H3H5 | |
| HEATLRCWALGFYPA | 221 | P10321 | |
| SLPSFCAVHLEWIQY | 1546 | Q9H6A9 | |
| AFLGWFDYCDHLITE | 341 | Q86V87 | |
| FAHPSLWQLGVDYFD | 411 | Q9BW27 | |
| HGQPGYNSWRAFCDL | 561 | P22079 | |
| QYHVQFFGDAPERAW | 261 | O96028 | |
| LLHNPCAEEGFEFWS | 81 | Q9H4M3 | |
| EANSQYFHLAAWAVP | 366 | Q14332 | |
| DRCEWFYEHLHSGQP | 526 | Q8IYU2 | |
| SLFVFPCQWNYRPDH | 331 | Q4G148 | |
| YEQLPEDVGHCFVTW | 1351 | O60229 | |
| PHIFAIANECYRCLW | 131 | Q9HD67 | |
| LLTEDYDNHPFWFRC | 256 | Q6P1A2 | |
| ADSAWIPFREHCYSF | 1266 | Q9UBG0 | |
| WLCYDALVHFALEGP | 46 | Q9BY08 | |
| FTPYSLLWNNCEHFV | 151 | O95237 | |
| LYQHQPALEWCVAVY | 196 | Q96S97 | |
| DWYPHSRLFDQAFGL | 21 | P04792 | |
| WPSALVLCYFLETNA | 96 | A6NDL7 | |
| LFYLHCVLSFPENWP | 366 | Q2VPB7 | |
| ALLVEFYAPWCGHCQ | 61 | Q13087 | |
| FLEALGYTWHDTCFV | 551 | Q96HC4 | |
| VDHCFPEYDIWTQFV | 386 | A6NEC2 | |
| HCYLDLVYQGWQPSR | 656 | Q13219 | |
| EGYNWCHDRNVVTIF | 246 | P62714 | |
| EGYNWCHDRNVVTIF | 246 | P67775 | |
| FDCLGPHFTWLQAVF | 56 | Q02509 | |
| VANCSDPEWNETFHY | 86 | Q68DD2 | |
| VDSDQLLYQHFWCLP | 376 | Q9BZE1 | |
| HEATLRCWALGFYPA | 221 | P01889 | |
| VVAAFALCWGPYHVF | 251 | Q9Y5Y4 | |
| ALCWGPYHVFSLLEA | 256 | Q9Y5Y4 | |
| TIIDWAPRGQFYHNC | 1021 | P63135 | |
| QHPWLDLSSLGFCYL | 136 | Q86Y01 | |
| PGFENILFAHSSWYT | 236 | Q6P4A8 | |
| AAFWLPYHVVNLAEA | 231 | Q15722 | |
| DLFAFAYHAWCLGLT | 126 | Q9NYA4 | |
| DFGATWHLLLPLCYH | 2046 | P78509 | |
| CHFFFNISGILLWYP | 476 | Q06495 | |
| CRISPANYEPVHWFL | 3026 | Q5VST9 | |
| NYISALNTLWHPECF | 486 | P49023 | |
| IFNLNCWGIPYLSKH | 11 | O60906 | |
| IHCNHRIPFGDWFEY | 236 | Q9H8P0 | |
| PYRDNLFCEWHLQGL | 2356 | O60494 | |
| EANSQYFHLAAWAVP | 441 | Q9UP38 | |
| ANSQYFHLAAWAVPA | 376 | O75084 | |
| HYFFTPCILTQWVLG | 2491 | Q8NCM8 | |
| YCNEDSWQLPIHAAA | 241 | Q9Y575 | |
| FYCSRTQNEGHPKWF | 71 | Q9Y680 | |
| LDSLYLHGNPWTCDC | 211 | Q6WRI0 | |
| FLVCNIDYGHIQPVW | 361 | Q6WRI0 | |
| LWFRYGAHQPENLCL | 66 | O95976 | |
| ILGFDTPHYWLCDNR | 936 | Q9Y4C1 | |
| NFDYLTRDWSILGPH | 1526 | Q13936 | |
| FILVTLGCWFHCRYN | 66 | Q5RI15 | |
| VLHCQFSAWYPFFRG | 6 | O75794 | |
| IIDWAPRGQFYHNCS | 151 | P61566 | |
| TIIDWAPRGQFYHNC | 261 | P61570 | |
| TIIDWAPRGQFYHNC | 261 | Q69384 | |
| IIDWAPRGQFYHNCS | 151 | P61567 | |
| WPQEAGEYAVHVLCN | 636 | P21333 | |
| PQNLDHWLDYGAFCL | 666 | Q5T0N1 | |
| QYSGDPRIEWHLNAF | 201 | Q05707 | |
| DAHCEVAVNWYAPLV | 301 | Q86SF2 | |
| FQNDIHVYPIWLCPF | 401 | Q15392 | |
| RDHCQWGSPFSVIEY | 131 | Q96F85 | |
| GLFAFCWLPNHVIYL | 271 | P30550 | |
| NVPLHYACFWGQDQV | 101 | Q13418 | |
| AWGILYVHSCPSFSN | 191 | Q96LW7 | |
| ITDNFCYFRHADPTW | 151 | Q92949 | |
| YPDSHFQCYIVRWDN | 1096 | Q9NSI6 | |
| IIDWAPRGQFYHNCS | 261 | P61565 | |
| IIDWAPRGQFYHNCS | 151 | Q9HDB8 | |
| HEATLRCWALGFYPA | 221 | P04439 | |
| HCESLRGSFPILYWF | 496 | Q96P31 | |
| SCLNGWFQHRCPLAY | 501 | Q9UH90 | |
| WFQHRCPLAYLGCTF | 506 | Q9UH90 | |
| FPWSGLIYIHCDDGQ | 2206 | Q8TEP8 | |
| VAWNLHGILRDFYSP | 136 | P57739 | |
| WLSFASAVCHPLIYG | 311 | Q8N6U8 | |
| CPLYSFDRAAVLHVW | 1006 | Q13683 | |
| TLIDWAPRGQFYHNC | 261 | Q902F9 | |
| RGCWILYEQPNFEGH | 1061 | Q9Y4K1 | |
| GELWFVNFYSPGCSH | 146 | Q8IXB1 | |
| VATVCTQFGLWTPHY | 236 | Q96CH1 | |
| PGYRWIAFCHNILSC | 46 | Q30KP8 | |
| LQGRLYISPNWLCFH | 101 | Q8IUY3 | |
| YISPNWLCFHASLFG | 106 | Q8IUY3 | |
| NNRDFPDWAHCYSDL | 416 | P51168 | |
| PAWGHCFYRLYQDLE | 591 | P51172 | |
| VFLHLLPEAWAYTCS | 121 | Q96H72 | |
| PDVCRHYFGSFGQWS | 186 | Q8NBW4 | |
| PRNLVMDHCWDSFIY | 2786 | Q6ZTR5 | |
| VDHCFPEYDIWTQFV | 386 | P55786 | |
| NFDYLTRDWSILGPH | 1466 | Q01668 | |
| PVSWYNHFLGDRDVL | 131 | Q96B33 | |
| YTLPRCHDWQAADQF | 11 | Q13474 | |
| WLFAPLETLNLYHNC | 131 | Q5VUJ6 | |
| PFLLEAQRGCYTWHS | 56 | Q5VU65 | |
| WQDYEGRTPLHFAVA | 216 | Q9Y283 | |
| IFWFDAHEINYGACV | 86 | Q8NH60 | |
| HAWISIPFCFAYTLA | 26 | Q8NGK4 | |
| HLLFPCYQWLEGAGT | 101 | O15296 | |
| YAICEHISPVLAWGF | 531 | Q8NAN2 | |
| GFPCSWTFFHHLREQ | 166 | P19526 | |
| VNSVCWAPHDYGLIL | 106 | P55735 | |
| VYCPVQWEYGRLNLH | 476 | P47897 | |
| YDWAERCQHVPFGVV | 366 | Q5T160 | |
| LWATDHYQPLRIFAG | 611 | Q15542 | |
| WLRYFNSTCNPLIHG | 296 | Q9P1P4 | |
| ENPMAHFLLGRWCYQ | 361 | Q96TC7 | |
| GLGNVWRFPYLCQSH | 51 | Q695T7 | |
| WHDYQYRIIAQACDP | 161 | Q96JX3 | |
| VPTFRVQDYCWEDHG | 346 | Q9Y6P5 | |
| YIVFCGENWPHLTRV | 81 | Q8NEQ6 | |
| SAPWAALAHSREQYC | 296 | Q5TGY1 | |
| LLPFLFCGHFWQLYN | 271 | A0PK00 | |
| CCFWPLGIAAFYLSH | 191 | Q9H7V2 | |
| DLINACSHYGLIYPW | 826 | Q969F9 | |
| YHQPSWIFCNGRLDL | 486 | Q5K651 | |
| LLESYFHVLNADWPA | 276 | Q6ZNJ1 | |
| SFQLSYGGLRHFCWP | 971 | Q86YN6 | |
| AICEEIHLYGFWPFG | 311 | O43173 | |
| FPQIRWHQTADFGYV | 336 | Q9HAT2 | |
| FAHYDVQSLLFDWAP | 116 | Q96FS4 | |
| APAFECVYNRAALLW | 496 | Q9Y2G9 | |
| HFLVAEWNEPSINFY | 126 | P21673 | |
| GQWFTVLERYHPTTC | 311 | Q13203 | |
| HCATPEQWAEFFYVL | 771 | Q8WX94 | |
| ELSGLPFYWNFHCML | 111 | Q9H9Q4 | |
| WTYNLAFCGPNEINH | 161 | Q8NGP6 | |
| SLIPWCFFVDNHGYN | 101 | P14410 | |
| LAFWLNEPHFVGSAY | 206 | Q9C0C4 | |
| LQYPVYWDHLEFCDG | 76 | Q9NZD8 | |
| HLWNSFCSVDPYNPQ | 476 | Q5SWA1 | |
| CVWLFRHPSLNGYLQ | 6 | O75570 | |
| LFFHWYDSLTGVPAQ | 191 | Q8TCX5 | |
| VLSPNFVQSEWCHYE | 696 | Q15399 | |
| RIFPHLYLGSEWNAA | 331 | Q8TE77 | |
| QRYCEGHFSLSQWDP | 46 | Q5BKT4 | |
| VCWTAHAIIRDFYNP | 136 | P56747 | |
| VCWTAHAIIQDFYNP | 136 | O95484 | |
| IITFFLCWCPYHTLN | 266 | Q99788 | |
| NYHVRFRCPLEASWG | 136 | Q8IUL8 | |
| AVPYFSNLVWFIGSH | 216 | Q2KHT3 | |
| ACFPDLQHGYLVAWL | 56 | Q8IV77 | |
| HFWRYFHCPADSSEL | 101 | Q8TBE1 | |
| CVSQWGHDFRPDYLR | 161 | O94762 | |
| QLYYPCEHVAWAADA | 101 | Q96HA9 | |
| DGDWEHCYLPSAFSQ | 1931 | Q63HN8 | |
| QDLICDHSLSPGWYR | 51 | Q8N2E2 | |
| LPCDIYWHGVSFHDN | 251 | Q8NHH1 | |
| ARIHFEDYGCWDTIN | 276 | P32241 | |
| GSLAQYSCADPQWHV | 806 | Q96KV7 | |
| YPRWFTLGHLESQQC | 791 | Q9P217 | |
| DWIFQCISYHAPEAL | 396 | Q7Z3J2 | |
| PEIHAQVFDYLCELW | 1081 | Q6GYQ0 | |
| NILFWQACEYFNHVP | 741 | O14924 | |
| CVHRSTIYPVGQFWE | 2431 | P04275 | |
| LVPGHNRTWANYSEC | 156 | Q03431 | |
| LPTFRAQDYTWENHG | 346 | P58005 | |
| RAGLPSWQYQCIHFF | 91 | Q495Y7 | |
| GHSFCRPCLYLNWQD | 31 | Q9BSJ1 | |
| CQLAYWLHALPELYF | 166 | Q15035 | |
| CPEEFLTGHYWALFD | 111 | Q96MI6 | |
| FAHLFQLVSPWTCGA | 861 | O95759 | |
| FAVDLANVWRFPYLC | 76 | Q01959 | |
| CAVSAALHWDPVNGY | 686 | Q6ZS81 | |
| ASSIWYITFFCPHDL | 86 | Q9NVV0 | |
| PETSCQSFWHFRYQE | 41 | Q9GZW5 | |
| LNPGVAVEFAWCLHY | 251 | Q96DC7 | |
| NEAAHWFLAVVCFPG | 761 | Q9GZR1 | |
| CVSPEIFWSALGNLY | 111 | Q70EL3 | |
| IYCWHIGQPNEALKF | 1036 | Q8NDW8 | |
| FYQDPSFHLSLAWCV | 201 | Q9BQ65 | |
| FFYVALCLLWAGHRD | 6 | A0A0K0K1A3 | |
| DYCWLSPHNAPVLFL | 276 | Q8IY26 | |
| VLSPNFVQSEWCHYE | 701 | Q9Y2C9 | |
| FNPDGYFWAIIHLLC | 146 | Q24JQ0 | |
| CDLPVENAVYTHWYL | 41 | A0A0C4DH27 | |
| NYISALSALWHPDCF | 356 | O43294 | |
| FFYVALCLLWAGHRD | 6 | A0A0K0K1G8 | |
| ATCIWDHGPSYLLRF | 106 | O43692 | |
| RGHQNWVYSCAFSPD | 211 | Q9Y6I7 | |
| AVLWAFGCTAHDIVY | 246 | Q9Y2P4 | |
| HFLRDGWCLEAFSYA | 761 | O60602 | |
| FLLYCHSAGQWFAVE | 1706 | Q96QT4 | |
| AFIGNAYIAVDWHPT | 986 | P35125 | |
| RCDPISGHVSLFWYQ | 41 | A0A1B0GX51 | |
| VLHCGPWSFQFAVNL | 31 | Q12836 | |
| EPLWAYFCDFRDITH | 371 | P29597 | |
| NEWYVCQASGAPSHL | 621 | Q96T25 | |
| PTYIGLSNILCWAFH | 206 | Q8NFZ6 | |
| VVFHWPRNDYDQLLC | 3441 | Q5THJ4 |